Do patients undergoing percutaneous coronary intervention benefit from clopidogrel pretreatment?

被引：2
作者：
Weintraub, WS
机构：
[1] Christiana Care Hlth Serv, Div Cardiol, Newark, DE 19718 USA
[2] Christiana Care Hlth Serv, Christiana Ctr Outcomes Res, Newark, DE 19718 USA
来源：
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2006年 / 3卷 / 01期
关键词：
clopidogrel; percutaneous coronary intervention; ST-segment elevation myocardial infarction;
D O I：
10.1038/ncpcardio0398
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12 / 13
页数：2
相关论文
共 6 条
[1]   Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention - Results from The Clopidogrel for the Reduction of Events During Observation (CREDO) trial [J].
Beinart, SC ;
Kolm, P ;
Veledar, E ;
Zhang, ZF ;
Mahoney, EM ;
Bouin, O ;
Gabriel, S ;
Jackson, J ;
Chen, R ;
Caro, J ;
Steinhubl, S ;
Topol, E ;
Weintraub, WS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) :761-769
[2]   Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [J].
Mehta, SR ;
Yusuf, S ;
Peters, RJG ;
Bertrand, ME ;
Lewis, BS ;
Natarajan, MK ;
Maimberg, K ;
Rupprecht, HJ ;
Zhao, F ;
Chrolavicius, S ;
Copland, I ;
Fox, KAA .
LANCET, 2001, 358 (9281) :527-533
[3]   Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation [J].
Sabatine, MS ;
Cannon, CP ;
Gibson, CM ;
Lopez-Sendon, JL ;
Montalescot, G ;
Theroux, P ;
Claeys, MJ ;
Cools, F ;
Hill, KA ;
Skene, AM ;
McCabe, CH ;
Braunwald, E ;
Braunwald, E ;
Cannon, C ;
Sabatine, M ;
McCabe, C ;
McCagg, A ;
Job, B ;
Gaudin, C ;
Thizon-de Gaulle, I ;
Blumenthal, M ;
Saini, R ;
Delaet, I ;
Townes, L ;
Anhalt, D ;
van Holder, K ;
Skene, A ;
Hill, K ;
Braunwald, E ;
Cannon, C ;
Sabatine, M ;
McCabe, C ;
Job, B ;
Gaudin, C ;
Thizon-de Gaulle, I ;
Blumenthal, M ;
Saini, R ;
Delaet, I ;
Townes, L ;
Skene, A ;
Ardissino, D ;
Aylward, P ;
Bertrand, M ;
Bode, C ;
Budaj, A ;
Claeys, M ;
Dellborg, M ;
Ferreira, R ;
Gershlick, A ;
Huber, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12) :1179-1189
[4]   Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics -: The PCI-CLARITY study [J].
Sabatine, MS ;
Cannon, CP ;
Gibson, CM ;
López-Sendón, JL ;
Montalescot, G ;
Theroux, P ;
Lewis, BS ;
Murphy, SA ;
McCabe, CH ;
Braunwald, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (10) :1224-1232
[5]   Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial [J].
Steinhubl, SR ;
Berger, PB ;
Mann, JT ;
Fry, ETA ;
DeLago, A ;
Wilmer, C ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19) :2411-2420
[6]   Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation [J].
Weintraub, WS ;
Mahoney, EM ;
Lamy, A ;
Culler, S ;
Yuan, Y ;
Caro, J ;
Gabriel, S ;
Yusuf, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (06) :838-845
1